Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2018.
Subjects:	United States. > Food and Drug Administration > Rules and practice. Drugs > United States > Testing. Drug approval > United States. Drugs > Safety regulations > United States. Medical instruments and apparatus > Safety regulations > United States. Generic drugs > United States. Competition > United States. Antitrust law > United States. United States. > Food and Drug Administration. Antitrust law. Competition. Drug approval. Drugs > Safety regulations. Drugs > Testing. Generic drugs. Medical instruments and apparatus > Safety regulations. United States. Legislative hearings. Rules.
Online Access:	https://purl.fdlp.gov/GPO/gpo93483

Description
Item Description:	"Serial no. 115-27."
Physical Description:	1 online resource (iv, 51 pages)